Exact Mass: 1168.4129472
Exact Mass Matches: 1168.4129472
Found 19 metabolites which its exact mass value is equals to given mass value 1168.4129472
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicotinic acid 10,14-diacetoxy-21-(2-acetoxy-2-methylpropionyloxy)-13-(benzoyloxy)-5,7,8,9,10,12,13,14,15,17,18,19-dodecahydro-20-hydroxy-8,18,19,20-tetramethyl-5,17-dioxo-22-(3,4,5-trimethoxybenzoyloxy)-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-12-ylmethyl ester
Nicotinic acid 10,14-diacetoxy-21-(2-acetoxy-2-methylpropionyloxy)-13-(benzoyloxy)-5,7,8,9,10,12,13,14,15,17,18,19-dodecahydro-20-hydroxy-8,18,19,20-tetramethyl-5,17-dioxo-22-(3,4,5-trimethoxybenzoyloxy)-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-12-ylmethyl ester
Motexafin gadolinium hydrate
Motexafin gadolinium hydrate
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents
N,N-{(1S,1R,2S,2S,8R,11S,14R,17S,21R,24S,27S)-27-[(butan-2-yl)sulfanyl]-2,2,3,11,13,16,24,26-octamethyl-2,5,9,12,15,18,22,25-octaoxo-6,19-dioxa-28-thia-3,10,13,16,23,26-hexaazadispiro[cyclopropane-1,4-bicyclo[12.12.3]nonacosane-17,1-cyclopropane]-8,21-diyl}bis(3-hydroxyquinoline-2-carboxamide)
N,N-{(1S,1R,2S,2S,8R,11S,14R,17S,21R,24S,27S)-27-[(butan-2-yl)sulfanyl]-2,2,3,11,13,16,24,26-octamethyl-2,5,9,12,15,18,22,25-octaoxo-6,19-dioxa-28-thia-3,10,13,16,23,26-hexaazadispiro[cyclopropane-1,4-bicyclo[12.12.3]nonacosane-17,1-cyclopropane]-8,21-diyl}bis(3-hydroxyquinoline-2-carboxamide)
C56H68N10O14S2 (1168.4357668000002)
GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-3)[NeuAc(a2-6)]GalNAc
GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc
Gal(b1-4)[NeuAc(a2-6)]GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc
Gal(b1-4)[NeuAc(a2-6)]GlcNAc(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)[GalNAc(a1-4)]Gal(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-3)[GalNAc(a1-4)]Gal(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-3)[GalNAc(a1-4)]Gal(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)[GalNAc(a1-4)]Gal(b1-3)[NeuAc(a2-6)]GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)[NeuAc(a2-6)]b-GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)[NeuAc(a2-6)]b-GalNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)[NeuAc(a2-6)]b-GlcNAc
NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-3)[NeuAc(a2-6)]b-GlcNAc
Gal(b1-4)[NeuAc(a2-6)]GlcNAc(b1-3)[NeuAc(a2-6)]a-GalNAc
Gal(b1-4)[NeuAc(a2-6)]GlcNAc(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]a-GalNAc
NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]a-GalNAc
(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
UK 63052
UK 63052
C56H68N10O14S2 (1168.4357668000002)
A cyclodepsipeptide antibiotic that is isolated from Streptomyces sp. SNA15896 and also exhibits antitumour activity.